Literature DB >> 3122966

Human retroviral infections in The Gambia: prevalence and clinical features.

D C Mabey1, R S Tedder, A S Hughes, P T Corrah, S J Goodison, T O'Connor, F C Shenton, S B Lucas, H C Whittle, B M Greenwood.   

Abstract

The prevalence of infection with human immunodeficiency virus type 1 (HIV 1) is lower in west Africa than in other parts of Africa. Human immunodeficiency virus type 2 (HIV 2) has been isolated from west African patients and may be transmitted by heterosexual contact. The prevalence of antibodies to HIV 1 and HIV 2 was studied by enzyme linked immunosorbent assay (ELISA) among various groups of subjects in The Gambia, west Africa--namely, prostitutes, blood donors, patients with suspected infection with HIV, patients attending clinics for sexually transmitted diseases, and patients with tuberculosis. Four cases of the acquired immune deficiency syndrome (AIDS) due to infection with HIV 1 were detected, of which three had been acquired abroad. No other subject was found to be positive for antibodies to HIV 1. The prevalence of antibodies to HIV 2 among the patients attending clinics for sexually transmitted diseases was found to have increased from 0/117 in 1984 to 10/185 (5%) in the last six months of 1986. One out of 278 blood donors was positive for antibodies to HIV 2 as were 10 out of 80 patients with suspected AIDS. HIV 2 seems to be transmitted sexually, and, although it has been present for only a short time, it seems to be endemic in The Gambia and is pathogenic.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Behavior; Demographic Factors; Developing Countries; Diseases; English Speaking Africa; Epidemiologic Methods; Examinations And Diagnoses; Gambia; Hiv Infections; Laboratory Examinations And Diagnoses; Measurement; Population; Population Characteristics; Prevalence; Research Methodology; Research Report; Sex Behavior; Viral Diseases; Western Africa

Mesh:

Year:  1988        PMID: 3122966      PMCID: PMC2544698          DOI: 10.1136/bmj.296.6615.83

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Isolation of a new human retrovirus from West African patients with AIDS.

Authors:  F Clavel; D Guétard; F Brun-Vézinet; S Chamaret; M A Rey; M O Santos-Ferreira; A G Laurent; C Dauguet; C Katlama; C Rouzioux
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

2.  Antibodies to HTLV-IV associated with chronic, fatal illness resembling "slim" disease.

Authors:  K Mølbak; E Lauritzen; D Fernandes; B Böttiger; G Biberfeld
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

3.  Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients.

Authors:  F Brun-Vezinet; M A Rey; C Katlama; P M Girard; D Roulot; P Yeni; L Lenoble; F Clavel; M Alizon; S Gadelle
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

4.  A new reagent which may be used to introduce sulfhydryl groups into proteins, and its use in the preparation of conjugates for immunoassay.

Authors:  R J Duncan; P D Weston; R Wrigglesworth
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Molecular cloning and polymorphism of the human immune deficiency virus type 2.

Authors:  F Clavel; M Guyader; D Guétard; M Sallé; L Montagnier; M Alizon
Journal:  Nature       Date:  1986 Dec 18-31       Impact factor: 49.962

6.  New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM).

Authors:  P J Kanki; F Barin; S M'Boup; J S Allan; J L Romet-Lemonne; R Marlink; M F McLane; T H Lee; B Arbeille; F Denis
Journal:  Science       Date:  1986-04-11       Impact factor: 47.728

7.  Human immunodeficiency virus type 2 infection associated with AIDS in West Africa.

Authors:  F Clavel; K Mansinho; S Chamaret; D Guetard; V Favier; J Nina; M O Santos-Ferreira; J L Champalimaud; L Montagnier
Journal:  N Engl J Med       Date:  1987-05-07       Impact factor: 91.245

8.  Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in Britain.

Authors:  R Cheingsong-Popov; R A Weiss; A Dalgleish; R S Tedder; D C Shanson; D J Jeffries; R B Ferns; E M Briggs; I V Weller; S Mitton
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

9.  Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast.

Authors:  F Denis; F Barin; G Gershy-Damet; J L Rey; M Lhuillier; M Mounier; G Leonard; A Sangare; A Goudeau; S M'Boup
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321

10.  AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa.

Authors:  J K Kreiss; D Koech; F A Plummer; K K Holmes; M Lightfoote; P Piot; A R Ronald; J O Ndinya-Achola; L J D'Costa; P Roberts
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

View more
  8 in total

Review 1.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

2.  Different serological HIV-2 results in three HIV-1-infected men from The Gambia.

Authors:  K H Marquart; H A Müller
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

3.  A non-Hodgkin's lymphoma in a patient with HIV-2 infection.

Authors:  R Colebunders; H De Vuyst; T Verstraeten; W Schroyens; E Van Marck
Journal:  Genitourin Med       Date:  1995-04

4.  Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

Authors:  Nuno R Faria; Ioannis Hodges-Mameletzis; Joana C Silva; Berta Rodés; Smit Erasmus; Stefania Paolucci; Jean Ruelle; Danuta Pieniazek; Nuno Taveira; Ana Treviño; Maria F Gonçalves; Sabelle Jallow; Li Xu; Ricardo J Camacho; Vincent Soriano; Patrick Goubau; João D de Sousa; Anne-Mieke Vandamme; Marc A Suchard; Philippe Lemey
Journal:  J Gen Virol       Date:  2011-12-21       Impact factor: 3.891

5.  First documented case of human immunodeficiency virus type 2 infection in an asymptomatic Swiss subject.

Authors:  P Bürgisser; L Odier; J Schüpbach; P C Frei
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

6.  Epidemiology of HIV and hepatitis B virus (HBV) in selected African and Asian populations.

Authors:  T Mertens; G Tondorf; M Siebolds; J P Kruppenbacher; S M Shrestha; G Mauff; L Gürtler; H J Eggers
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

7.  Human immunodeficiency viruses in patients attending a sexually transmitted disease clinic in London, 1982-7.

Authors:  C Loveday; L Pomeroy; I V Weller; J Quirk; A Hawkins; H Williams; A Smith; P Williams; R S Tedder; M W Adler
Journal:  BMJ       Date:  1989-02-18

8.  Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.

Authors:  Youngjee Choi; John Townend; Tim Vincent; Irfan Zaidi; Ramu Sarge-Njie; Assan Jaye; David B Clifford
Journal:  J Neurovirol       Date:  2011-03-22       Impact factor: 2.643

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.